CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Arthur Klausner to be a panelist at the 12th Annual Drug Delivery Partnerships Conference in San Diego, CA
News | 01. 21. 2008
